Monika Schmelz

  • 1759 Citations
  • 20 h-Index
1986 …2018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Monika Schmelz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S. D., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S., Karnad, A., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Perry, C. S., Groshen, S. & 5 others, Venkatakrishnan, K., Zhou, X., Sheldon-Waniga, E., Jane Leonard, E. & Mahadevan, D., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.

Research output: Contribution to journalArticle

  • 8 Scopus citations

    Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

    Kendrick, S., Rimsza, L. M., Scott, D. W., Slack, G. W., Farinha, P., Tan, K. L., Persky, D., Puvvada, S. D., Connors, J. M., Sehn, L., Gascoyne, R. D. & Schmelz, M., Jan 1 2017, In : Virchows Archiv. 470, 1, p. 113-117 5 p.

    Research output: Contribution to journalArticle

    5 Scopus citations

    A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

    Puvvada, S. D., Guillén-Rodríguez, J. M., Rivera, X. I., Heard, K., Inclan, L., Schmelz, M., Schatz, J. H. & Persky, D. O., Sep 5 2017, (Accepted/In press) In : Oncology (Switzerland).

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    Come in Out of the Cold: Alternatives to Freezing for Microbial Biorepositories

    Isaacs, E. & Schmelz, M., Feb 15 2017, In : Clinical Microbiology Newsletter. 39, 4, p. 27-34 8 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Pak2 regulates myeloid-derived suppressor cell development in mice

    Zeng, Y., Hahn, S., Stokes, J., Hoffman, E. A., Schmelz, M., Proytcheva, M., Chernoff, J. & Katsanis, E., Oct 10 2017, In : Blood Advances. 1, 22, p. 1923-1933 11 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations